Hematological Program

Click here to view the full program

Saturday, January 16, 2016


0730

Registration Desk Opens / Continental Breakfast

0750 – 0800

Welcome – Dr. Jagdish Butany, University Health Network, Toronto, ON

0800 – 0830

 

“Diagnostic Immunohistochemistry”
Dr. Martin Trotter, Providence Health Care, Vancouver, BC
(20 minute presentation, 10 minute Q&A)

At the end of this session, participants will be able to:

  • Explain the importance of the pre-analytic phase in quality and validity of immunohistochemistry stains.
  • Describe the technical components of an immunohistochemistry test and list the types of controls which should be used.
  • List the important components of new test validation for both class I and class II immunostains.

0830 – 0930

 

Quality Assurance in Hematological Pathology
Dr. Ruth Frances Padmore, University of Ottawa, Ottawa, ON
 (45 minute presentation, 15 minutes Q&A)

  • Quality in the hematology laboratory
  • Critical results – how are they handled
  • Safety in the Laboratory
  • Laboratory errors (pre analytic, analytic and post analytic)
  • Instrument selection and validation

09:30-10:00

Refreshment Break

10:00 –11:00

A Case Based Approach In Blood Transfusion
Dr. Irene Sadek , Dalhousie University, Halifax, NS
(45 minute presentation, 15 minutes Q&A)

  • Complex Cases in transfusion Medicine
  • Clinical problems in replacement therapy
  • Technical aspects of blood banking
  • Issues in laboratory utilization in transfusion medicine

1100-11:45

“Quality Assurance In Transfusion Medicine’’
Dr.  Irene Sadek, Dalhousie University, Halifax, NS
(20 minute presentation, 10 minute Q&A)

At the end of this session, participants will be able to:

  • Explain the purpose and basic principles of a quality assurance program in transfusion medicine.
  • List at least six (6) basis components of a transfusion medicie QA program.
  • Describe at least three (3) strategies through which error identification can lead to quality improvement as part of a quality assurance program in transfusion medicine.

11:45-12:45

Lunch:
Luncheon Seminar from 1200-1230
Dr. Brian Cummings, Grand River Hospital, Kitchener-Waterloo, ON
(20 minute presentation, 10 minute Q&A)

At the end of this session, participants will be able to:

  • Provide a brief overview of remuneration and working conditions for Pathologists in Canada.
  • Discuss the costs, benefits, opportunities and pitfalls of incorporation for Pathologists and assess whether it may be beneficial for their present or planned position.
  • Highlight some negotiation and tax tips as one finishes training and enters a practice.

1245 - 1345

“An Approach to Hemoglobinopathy Investigations”
Dr. Elaine Leung, University of Ottawa, Ottawa, ON
(45 minute presentation, 15 minute Q&A)

At the end of the session, participants will have an understanding of:

  • A practical approach to the investigation of the hemoglobinopathies.
  • The implications of the common haemoglobinopthies encountered in a clinical setting and how to advise clinicians regarding testing results.
  • When to refer samples to a reference lab for further investigations.
  • The interpretation of hemoglobinopathy investigations throughout infancy and early childhood. 

1345– 1445

“Coagulation and Thrombosis Selected Topics In Lab Hematology”
Dr. Artur Szkotak, Alberta Health Services, Edmonton, AB
(50 minute presentation, 10 minute Q&A)

At the end of this session, participants will be able to understand:

  • The key pre-analytic issues unique to coagulation testing
  • How to validate the INR for PT reporting.
  • How to validate the Heparin Therapeutic Range for PTT reporting.

14:45-1500

Refreshment Break

1500 – 1600

Approach to Pediatric Hematopathology Pathology
Chantale Pambrun IWK  Dalhousie University, Halifax, NS
(50 minute presentation, 10 minute Q&A)

At the end of this session, participants will be able to understand:

  • Bone marrow failure syndrome
  • Coagulation problems inpediatrics
  • Acute leukemia in Childhood

1600 – 1700

“The Molecular Genetics of Myeloid Malignancies”
Dr Aly Karsan, BC Cancer Agency and University of British Columbia Vancouver, BC
(50 minute presentation, 10 minute Q&A)

At the end of this session, participants will be able to understand:

  • The key pre-analytic, analytic and post-analytic steps of next-generation sequencing
  • The principal genes or gene families that are mutated in acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms
  • Apply knowledge of the genetic alterations in myeloid malignancies to hematopathology practice


Sunday, January 17

0700 – 0730

Continental Breakfast - Note early start

0840 - 0900

"Approach to the Hematological Pathology Fellowship Examination"
Dr. Ruth Frances Padmore, University of Ottawa, Ottawa, ON
(10 minute presentation, 10 minute Q&A)

 At the end of this session, participants will have a better understanding of the:

  • Overall format of the RCPSC exam in Hematological Pathology.
  • Have additional knowledge of the evaluation processes that guide the HP examination.
  •  Be aware of techniques to maximize success in all components of the exam.

0900– 1000

“Hematological Pathology:  Snapshot Review of Relevant Topics for an Emerging hematopathologist’’
Dr. David Conrad, Dalhousie University, Halifax, NS
(45 minute presentation, 15 minute Q&A)

 

1000 – 1015

  • Refreshment Break

1015 – 1115

“Approach to Work-up and Diagnosis of Hematological Disorders”
Dr. Monalisa Sur, McMaster University, Hamilton, ON
(45 minute presentation, 15 minute Q&A)

At the end of this session, participants will be able to:

  • Handle various specimens in the lab with a clinical diagnosis of a lymphoproliferative disorder.
  • Work up common reactive lymphadenopathies.
  • Use a pattern based approach to create a differential diagnosis and distinguish various indolent and aggressive lymphomas.

Understand the role (in diagnosis and prognosis) and judicious use of various ancillary tests such as immunohistochemistry, flow cytometry and molecular tests.

1115-1215

“Bone Marrow evaluation and Flow Cytometry”
Dr. Graeme Quest Toronto General Hospital, Toronto ON

At the end of this session, participants will have a better understanding of the:

  • Follow the principles of integrated bone marrow diagnostics.
  • Compare normal vs. abnormal patterns of the main antigen combinations used in the flow cytometric diagnosis of bone marrow.

Summarize principles of flow cytometry diagnostics of hematological malignancies.

1215-1300

Lunch (45 minutes)
“ Residents Digital Slide Collection”
Dr. Alison Osmond
(15 minute presentation)

“ ExperPath Presentation”
Dr. Launny Lowden
(15 minute presentation)

1300-1345

“Practical Approach to Hematological Evaluation of Peripheral Blood”
Dr. Allam Shawwa, Queen Elizabeth II Health Science Centre, Halifax, NS
(35 minute presentation, 10 minute Q&A)

At the end of this session, participants will have a better understanding of the:

  • Practical approach to diagnosis of anemia.
  • Practical approach to diagnosis of acute leukemia, myeloproliferative and myelodysplastic disorders. 
  • Practical approach to lymphocytosis with update on small lymphocyte disorders.

1345-1445

“Coagulopathy Investigations”
Dr. Rita Selby, University of Toronto, TorontoON
(20 minute presentation, 10 minute Q&A)

At the end of this session, participants will have a better understanding of the:

      • Assessment of Coagulation in the Laboratory
      • Important pre-analytical sources of error
      • Evaluating abnormal coagulation screening tests

1445 -1500

Coffee Break

1500 – 1600

“Investigations and Management of Transfusion Reactions”)
Dr. Christine Cserti-Gazdewich, University Health Network, Toronto, ON
(45 minute presentation, 15 minute Q&A)

At the end of this session, participants will have a better understanding of the:

  • Provide clear guidance toward clinical staff on the recognition and immediate management of Transfusion Reactions.
  • Provide clear guidance to the lab staff on the laboratory investigation of the Transfusion Reactions 

Understand and be able to discuss the utility of standard lab investigations for Transfusion Reactions and when to recommend/refer for complex or specialized testing.

1600-1605

Closing Comments

 


- last updated November 2016 -